» Articles » PMID: 33589645

Accuracy of Self-assessment of Real-life Functioning in Schizophrenia

Abstract

A consensus has not yet been reached regarding the accuracy of people with schizophrenia in self-reporting their real-life functioning. In a large (n = 618) cohort of stable, community-dwelling schizophrenia patients we sought to: (1) examine the concordance of patients' reports of their real-life functioning with the reports of their key caregiver; (2) identify which patient characteristics are associated to the differences between patients and informants. Patient-caregiver concordance of the ratings in three Specific Level of Functioning Scale (SLOF) domains (interpersonal relationships, everyday life skills, work skills) was evaluated with matched-pair t tests, the Lin's concordance correlation, Somers' D, and Bland-Altman plots with limits of agreement (LOA). Predictors of the patient-caregiver differences in SLOF ratings were assessed with a linear regression with multivariable fractional polynomials. Patients' self-evaluation of functioning was higher than caregivers' in all the evaluated domains of the SLOF and 17.6% of the patients exceeded the LOA, thus providing a self-evaluation discordant from their key caregivers. The strongest predictors of patient-caregiver discrepancies were caregivers' ratings in each SLOF domain. In clinically stable outpatients with a moderate degree of functional impairment, self-evaluation with the SLOF scale can become a useful, informative and reliable clinical tool to design a tailored rehabilitation program.

Citing Articles

Real-life functioning and duration of illness in schizophrenia: A mediation analysis.

Brasso C, Bellino S, Bozzatello P, Montemagni C, Rocca P Heliyon. 2025; 11(1):e41332.

PMID: 39958743 PMC: 11825250. DOI: 10.1016/j.heliyon.2024.e41332.


Beyond Detection: Towards Actionable Sensing Research in Clinical Mental Healthcare.

Adler D, Yang Y, Viranda T, Xu X, Mohr D, VAN Meter A Proc ACM Interact Mob Wearable Ubiquitous Technol. 2024; 8(4).

PMID: 39639863 PMC: 11620792. DOI: 10.1145/3699755.


Interview Versus Performance Assessment of Cognition as Predictors of Real-World Outcomes in a Large-Scale Cross-Sectional Study in Schizophrenia.

Pezzella P, Caporusso E, Mucci A, Bucci P, Giordano G, Amore M Schizophr Bull Open. 2024; 5(1):sgae020.

PMID: 39221412 PMC: 11362673. DOI: 10.1093/schizbullopen/sgae020.


Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia.

Giordano G, Pezzella P, Mucci A, Austin S, Erfurth A, Glenthoj B Front Psychiatry. 2024; 15:1333711.

PMID: 38356912 PMC: 10864497. DOI: 10.3389/fpsyt.2024.1333711.


The Discrepancy between Subjective and Objective Evaluations of Cognitive and Functional Ability among People with Schizophrenia: A Systematic Review.

Harris M, Blanco E, Howie H, Rempfer M Behav Sci (Basel). 2024; 14(1).

PMID: 38247682 PMC: 10812940. DOI: 10.3390/bs14010030.


References
1.
Koren D, Viksman P, Giuliano A, Seidman L . The nature and evolution of insight in schizophrenia: a multi-informant longitudinal study of first-episode versus chronic patients. Schizophr Res. 2013; 151(1-3):245-51. DOI: 10.1016/j.schres.2013.10.013. View

2.
Misdrahi D, Denard S, Swendsen J, Jaussent I, Courtet P . Depression in schizophrenia: the influence of the different dimensions of insight. Psychiatry Res. 2014; 216(1):12-6. DOI: 10.1016/j.psychres.2014.01.039. View

3.
Wongpakaran N, Wongpakaran T, Wedding D, Gwet K . A comparison of Cohen's Kappa and Gwet's AC1 when calculating inter-rater reliability coefficients: a study conducted with personality disorder samples. BMC Med Res Methodol. 2013; 13:61. PMC: 3643869. DOI: 10.1186/1471-2288-13-61. View

4.
Tait L, Birchwood M, Trower P . A new scale (SES) to measure engagement with community mental health services. J Ment Health. 2011; 11(2):191-8. DOI: 10.1080/09638230020023570-2. View

5.
Strauss G, Keller W, Buchanan R, Gold J, Fischer B, McMahon R . Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale. Schizophr Res. 2012; 142(1-3):88-92. PMC: 3502630. DOI: 10.1016/j.schres.2012.10.012. View